Correlation Between Tryp Therapeutics and NGM Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Tryp Therapeutics and NGM Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tryp Therapeutics and NGM Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tryp Therapeutics and NGM Biopharmaceuticals, you can compare the effects of market volatilities on Tryp Therapeutics and NGM Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tryp Therapeutics with a short position of NGM Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tryp Therapeutics and NGM Biopharmaceutica.
Diversification Opportunities for Tryp Therapeutics and NGM Biopharmaceutica
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Tryp and NGM is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Tryp Therapeutics and NGM Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NGM Biopharmaceuticals and Tryp Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tryp Therapeutics are associated (or correlated) with NGM Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NGM Biopharmaceuticals has no effect on the direction of Tryp Therapeutics i.e., Tryp Therapeutics and NGM Biopharmaceutica go up and down completely randomly.
Pair Corralation between Tryp Therapeutics and NGM Biopharmaceutica
If you would invest 250.00 in NGM Biopharmaceuticals on September 14, 2024 and sell it today you would earn a total of 0.00 from holding NGM Biopharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Tryp Therapeutics vs. NGM Biopharmaceuticals
Performance |
Timeline |
Tryp Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
NGM Biopharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Tryp Therapeutics and NGM Biopharmaceutica Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tryp Therapeutics and NGM Biopharmaceutica
The main advantage of trading using opposite Tryp Therapeutics and NGM Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tryp Therapeutics position performs unexpectedly, NGM Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NGM Biopharmaceutica will offset losses from the drop in NGM Biopharmaceutica's long position.Tryp Therapeutics vs. PsyBio Therapeutics Corp | Tryp Therapeutics vs. Pharmather Holdings | Tryp Therapeutics vs. Awakn Life Sciences | Tryp Therapeutics vs. SanBio Company Limited |
NGM Biopharmaceutica vs. Instil Bio | NGM Biopharmaceutica vs. Achilles Therapeutics PLC | NGM Biopharmaceutica vs. NextCure | NGM Biopharmaceutica vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Transaction History View history of all your transactions and understand their impact on performance |